Work

Real-world safety of first-line (1L) therapies for locally advanced or metastatic urothelial cancer (la/mUC) in the US.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.5_suppl.759

Authors: Amanda Nizam, Mairead Kearney, Valerie A. Morris, Seyed Hamidreza Mahmoudpour, Carroline Lobo, Jason Hoffman, Ilian Iliev, Prakirthi Yerram, Mark Guinter

Institutions: Cleveland Clinic, Merck KGaA, Darmstadt (Germany), Merck Healthcare KGaA, Darmstadt (Germany), EMD Serono, Inc. (United States), Flatiron Health (United States)

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407678362

Cites:

Cited by:

Related to: 10